A5088182329- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Pharmaceutical Practices and Patient Outcomes
- Behavioral Health and Interventions
- Global Health Care Issues
- Economic and Environmental Valuation
- Decision-Making and Behavioral Economics
- HIV/AIDS Research and Interventions
- Healthcare Policy and Management
- Legionella and Acanthamoeba research
- HIV/AIDS Impact and Responses
- Primary Care and Health Outcomes
- Energy, Environment, Economic Growth
- Medication Adherence and Compliance
- HIV/AIDS drug development and treatment
Centers for Disease Control and Prevention
2019-2021
Office of the Director
2016-2019
CT Group Of Institutions
2019
Behavioral economics provides an empirically informed perspective on how individuals make decisions, including the important realization that even subtle features of environment can have meaningful impacts behavior. This commentary examples from literature and recent government initiatives incorporate concepts behavioral in order to improve health, decision making, efficiency. The highlight potential for effectiveness public health policy at low cost. Although incorporating insights into has...
IntroductionTeam-based interventions for hypertension care have been widely studied and shown effective in improving outcomes. Few studies evaluated long-term effects of these interventions; none assessed broad-scale implementation. This study estimates the prospective health, economic, budgetary impact universal adoption a team-based intervention model that targets people with treated but uncontrolled U.S.MethodsAnalysis was conducted 2014−2015 using microsimulation model, constructed...
We used administrative claims data from 2014 on people with employer-sponsored health insurance to assess the proportion of patients taking antihypertensive medications, rates nonadherence these medication regimens, and out-of-pocket costs paid by patients. performed multivariate logistic regression analysis examine association between nonadherence. Results indicated that filled equivalent 13 monthly prescriptions $76 out pocket over calendar year; likelihood increased as (adjusted odds...
The objective of this study was to assess the potential health and budgetary impacts implementing a pharmacist-involved team-based hypertension management model in United States.In 2017, we evaluated care intervention among 3 targeted groups using microsimulation designed estimate cardiovascular event incidence associated spending cross-section individuals representative US population: it patients with: (1) newly diagnosed hypertension; (2) persistently (≥1 year) uncontrolled blood pressure...
Abstract Through the use of published estimates medical costs and new calculations productivity losses, we estimate lifetime economic burden 2014 Legionnaires’ disease cases in United States at ≈$835 million. This total includes $21 million losses caused by absenteeism $412 premature deaths.
Objectives: Research suggests that persons who are aware of the risk factors for cardiovascular disease (CVD) more likely to engage in healthy behaviors than not factors. We examined whether patients whose insurance claims included an International Classification Diseases, Ninth Revision (ICD-9) code associated with hypertension self-reported high blood pressure were fill antihypertensive medication prescriptions and less have CVD-related emergency department visits hospitalizations...